News

Depo-subQ provera 104 (medroxyprogesterone acetate injectable suspension) is a long-acting injectable contraception and a new formulation of medroxyprogesterone acetate, which is the same active ingredient as Depo-Provera contraceptive

Dowpharma will manufacture short interfering RNAs (siRNAs), the molecules that induce RNAi, for use in clinical trials. The Dowpharma contract service agreement will provide Alnylam with large quantities

Lannett has now been approved to market 2.5mg and 5mg doses of terbutaline sulfate tablets, making the company the second generic supplier approved to market a copycat version

The study, which was conducted in Brazil, enrolled 20 patients who had advanced head and neck cancer and continuing disease progression, with all patients having failed previous courses

The study is designed to evaluate the safety, tolerability and pharmacokinetics of single doses of up to six levels of AEOL 10150 in patients diagnosed with amyotrophic lateral

A total of 33 patients have been enrolled in this study, with 27 patients included in the highest dose group, where they receive an initial dose of 500mg

Posurdex is an investigational, bioerodable, extended release implant that delivers dexamethasone to the targeted disease site at the back of the eye for the treatment of macular edema.

This is the first of three planned subject dosing studies that SCOLR Pharma is conducting, in support of an abbreviated new drug application (ANDA) to the FDA later

This approval expands the label to include the treatment of multiple myeloma patients who have received at least one prior therapy, and thus doubles the number of patients